Search PubMed⌕ Search

Biomedical subjects

M Wojnarowski

Publications and source records attributed to M Wojnarowski.

44 records · Page 3Linked to original sources
PubMedDate not supplied

[Incubation period of varicella in children with neoplastic diseases].

Duration of varicella incubation period has been analysed in 21 pediatric patients with neoplastic diseases and in 59 children without immunological deficiency. In has been found, that incubation period has been significantly longer in children with neoplastic diseases (mean 19.58 days), than that in children without immunologic disorders (15.45 days). The difference was statistically significant (p < 0.001).

Adolescent↗
PubMedDate not supplied

[Results of acyclovir treatment of chickenpox and herpes zoster in children with immune tolerance].

Acyclovir was used for the treatment of Varicella-zoster virus infections in 53 children (10 neonates and 43 children aged between 2 an 15 years) with immunological system deficiency hospitalized at the Department of the Infectious Diseases of Childhood in the Medical Academy in Warszawa. The obtained results of therapy were favourable except one fatal case of the child with visceral dissemination of the virus prior to acyclovir treatment. Compared with other antiviral agents used by the authors previously, acyclovir proved to be the most effective.

Acyclovir↗
PubMedDate not supplied

[Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].

Fourteen children with chronic active hepatitis B treated with isoprinosine were followed-up for 3-8 years. In no child HBs antigen was eliminated. No seroconversion was noted in children in whom HBe antigen was eliminated. Anti-HBe antibodies were found in 11 children, including 6 children in whom they were present all the time following therapy, and 2 children in whom these antibodies reappeared after an initial elimination. These results suggest that the inhibition of hepatitis B virus replication produced by isoprinosine may be transient. Therefore, longer lasting immunomodulating therapy should be considered.

Adjuvants, Immunologic↗